Unlock instant, AI-driven research and patent intelligence for your innovation.

Nitric oxide donor type tetravalent platinum derivative, preparation method and medical use thereof

A compound and pharmaceutical technology, applied in the field of pharmacy, can solve the problems of unclear direct mechanism of action, affecting DNA replication of tumor cells, etc.

Active Publication Date: 2021-08-20
CHINA PHARM UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The direct action mechanism of NO on tumor cells is still unclear, and there are mainly three aspects reported so far: (1) NO reacts with intracellular superoxide anion to form peroxynitrite, which is protonated and decomposed into NO 2 And hydroxyl free radicals, hydroxyl free radicals can combine with various molecules of tumor cells, thereby causing tumor cell damage, such as lipid peroxidation, protein, amino acid cross-linking reaction; (2) NO is very easy to combine with Fe-S center-containing Protein Fe forms Fe-NO, which causes the degradation of Fe-S prosthetic group and aconitase on the mitochondrial respiratory chain, thus preventing the synthesis of intracellular energy and inducing apoptosis; (3) NO can directly act on the reduction of ribonucleic acid Enzymes that affect the replication of tumor cell DNA, and can also nitrate DNA to inhibit tumor cell proliferation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nitric oxide donor type tetravalent platinum derivative, preparation method and medical use thereof
  • Nitric oxide donor type tetravalent platinum derivative, preparation method and medical use thereof
  • Nitric oxide donor type tetravalent platinum derivative, preparation method and medical use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047]

[0048] Compound I 2 The synthesis of: prolinol (I 1 , 10g), methanol solution (5.4mol / L) of sodium methoxide (5.4mol / L) 17.8g mixed into the polytetrafluoro container, add anhydrous ether 200mL, the reaction system N 2 After the replacement, nitrogen monoxide (NO) gas was introduced to make the pressure reach 0.4-0.8 MPa, and the reaction was carried out in a sealed greenhouse for 24 hours. Post-processing, let go of unreacted excess NO gas, the pressure will be normal pressure, after opening the container, pour the reaction solution into 1L of anhydrous ether to precipitate a large amount of white solid, filter, and wash the filter cake 3 times with ether, As for drying at room temperature in a vacuum drying oven for 2 hours, the collected white product is compound I 2 . Compound I obtained 2 The next reaction was carried out directly without purification.

[0049]

[0050] Compound I 3a and I 3b The synthesis of: take 1g compound I 2 and 5mL DMF were a...

Embodiment 2

[0063]

[0064] Compound II 2 Synthesis of: Boc-piperazine (II 1 , 20mL), methanol solution (5.4mol / L) of sodium methoxide (5.4mol / L) 50.79mL mixed into the polytetrafluoro container, add anhydrous ether 200mL, the reaction system N 2 After the replacement, nitrogen monoxide (NO) gas was introduced to make the pressure reach 0.4-0.8 MPa, and the reaction was carried out in a sealed greenhouse for 24 hours. Post-treatment, let go of unreacted excess NO gas, make the pressure drop to normal pressure, open the container, pour the reaction solution into 1L of anhydrous ether to precipitate a large amount of white solid, filter, and wash the filter cake 3 times with ether, As for drying at room temperature in a vacuum drying oven for 2 hours, the white product is collected, which is compound II 2 . Compound II obtained 2 The next reaction was carried out directly without purification.

[0065]

[0066] Compound II 3 Synthesis: take 1g of compound II 2 and 5mL DMF were ...

Embodiment 3

[0081] Embodiment 3: Compound I 5a Proliferation inhibitory activity of human ovarian tumor cell A2780 and normal human ovarian cell IOSE80

[0082] Cells in logarithmic growth phase were divided into 1×10 5 cells / well were seeded in 96-well plate, placed at 37°C, 5% CO 2 Cultured under conditions until the cells were 90% confluent, then incubated with serum-free DMEM medium for 2 h to synchronize the cells. Subsequently, the supernatant was discarded, and different concentrations of CDDP, CHP, I 4a , I 5a DMEM was incubated for 72 h, and 20 μL of MTT solution (5 mg / mL) was added to each well 4 h before the end of the incubation. After the incubation, discard the supernatant of each well, add 150 μL DMSO to each well, shake on a cell shaker for 10 minutes, and measure the OD with a microplate reader after the crystals are fully dissolved. 570 . .The results are expressed as mean±SD, and then the IC is obtained by fitting through GraphPad Prism 6 according to the inhibiti...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a nitric oxide donor type tetravalent platinum derivative, a preparation method and the application thereof as a whole bio-orthogonal prodrug in antitumor drugs. The compound in the present invention can be selectively activated in tumor cells, and the tetravalent platinum in its structure is reduced to cisplatin, and at the same time, cisplatin, as a new bioorthogonal catalyst, catalyzes the partial release of NO donor fragments NO, which cooperates with cisplatin to exert anti-tumor activity; while the compound does not have the above process in normal cells, so it has better safety.

Description

technical field [0001] The invention belongs to the technical field of pharmacy, and relates to a preparation method and application of a nitric oxide (NO) donor containing a tetravalent platinum complex, in particular to a new tetravalent platinum complex with tumor selectivity Small molecules with NO donor azonium dialkoxide fragments. Background technique [0002] At present, the morbidity and mortality of malignant tumors have been showing a significant upward trend, and chemotherapy was once the standard therapy for cancer treatment. However, due to the lack of targeting, traditional small molecule drugs will accidentally kill normal cells while killing tumor cells, causing serious toxic and side effects, so their wide application in clinical practice is limited. As an emerging discipline, bioorthogonal chemistry is widely used in labeling, tracking, manipulating and activating target molecules through bond formation and bond breaking. In recent years, some bioorthogo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07F15/00A61K31/555A61P35/00
CPCA61P35/00C07F15/0093
Inventor 张红花黄张建吴建兵张奕华孙涛朱杰朱明超
Owner CHINA PHARM UNIV